{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T23:50:20Z","timestamp":1783813820838,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jchromb.2015.07.001","type":"journal-article","created":{"date-parts":[[2015,7,19]],"date-time":"2015-07-19T10:02:34Z","timestamp":1437300154000},"page":"181-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Development and validation of a sensitive HPLC\u2013MS\/MS method for determination of chidamide (epidaza), a new benzamide class of selective histone deacetylase inhibitor, in human plasma and its clinical application"],"prefix":"10.1016","volume":"1000","author":[{"given":"Ruolan","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taoyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuona","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifang","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyun","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2015.07.001_bib0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.gde.2006.02.015","article-title":"Histone modifications: signalling receptors and potential elements of a heritable epigenetic code","volume":"16","author":"Nightingale","year":"2006","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.jchromb.2015.07.001_bib0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jchromb.2015.07.001_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2012.06.008","article-title":"Cancer genetics and epigenetics: two sides of the same coin?","volume":"22","author":"You","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jchromb.2015.07.001_bib0020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ceb.2013.01.001","article-title":"Targeting histone modifications-epigenetics in cancer","volume":"25","author":"Waldmann","year":"2013","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.jchromb.2015.07.001_bib0025","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.jchromb.2015.07.001_bib0030","doi-asserted-by":"crossref","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: the histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.jchromb.2015.07.001_bib0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jchromb.2015.07.001_bib0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2008.08.016","article-title":"HDAC family: what are the cancer relevant targets","volume":"277","author":"Witt","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jchromb.2015.07.001_bib0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jchromb.2015.07.001_bib0050","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1007\/s00018-014-1656-6","article-title":"Histone deacetylase inhibitors and cell death","volume":"71","author":"Zhang","year":"2014","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.jchromb.2015.07.001_bib0055","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1172\/JCI61205","article-title":"New molecular insights into peripheral T cell lymphomas","volume":"122","author":"Pileri","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jchromb.2015.07.001_bib0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI69738","article-title":"New and emerging HDAC inhibitors for cancer treatment","volume":"124","author":"West","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jchromb.2015.07.001_bib0065","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.3390\/molecules20033898","article-title":"Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents","volume":"20","author":"Mottamal","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.jchromb.2015.07.001_bib0070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PPO.0b013e3182a09e07","article-title":"Histone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinoma","volume":"19","author":"Ramakrishnan","year":"2013","journal-title":"Cancer J."},{"key":"10.1016\/j.jchromb.2015.07.001_bib0075","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s40265-014-0275-8","article-title":"Belinostat first global approval","volume":"74","author":"Poole","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.jchromb.2015.07.001_bib0080","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2217\/fon.13.220","article-title":"Romidepsin for cutaneous T-cell lymphoma","volume":"9","author":"Prince","year":"2013","journal-title":"Future Oncol."},{"key":"10.1016\/j.jchromb.2015.07.001_bib0085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1172\/JCI71605","article-title":"Cancer epigenetics drug discovery and development: the challenge of hitting the mark","volume":"124","author":"Campbell","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jchromb.2015.07.001_bib0090","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00280-011-1766-x","article-title":"Chidamide (CS055\/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity","volume":"69","author":"Ning","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jchromb.2015.07.001_bib0095","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3892\/or.2014.3595","article-title":"Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax\/Bcl-2 and P21 in pancreatic cancer","volume":"33","author":"Zhao","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jchromb.2015.07.001_bib0100","doi-asserted-by":"crossref","first-page":"e70522","DOI":"10.1371\/journal.pone.0070522","article-title":"Increased PRAME- specific CTL killing of acute myeloid leukemia cells by either a novel histone deacetylase inhibitor chidamide alone or combined treatment with decitabine","volume":"8","author":"Yao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jchromb.2015.07.001_bib0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bbrc.2013.03.059","article-title":"Chidamide, a novel histone deacetylase inhibitor, synergistically enhances gemcitabine cytotoxicity in pancreatic cancer cells","volume":"434","author":"Qiao","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jchromb.2015.07.001_bib0110","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.biopha.2014.03.011","article-title":"Non-toxic dose chidamide synergistically enhances platinum-induced DNA damage responses and apoptosis in non-small-cell lung cancer cells","volume":"68","author":"Zhou","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jchromb.2015.07.001_bib0115","first-page":"1503","article-title":"Antitumor activity of Chidamide in hepatoular carcinoma lines","volume":"5","author":"Wang","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jchromb.2015.07.001_bib0120","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbrc.2010.01.011","article-title":"A novel histone deacetylase inhibitor Chidamide induces apoptosis of human colon cancer cells","volume":"392","author":"Liu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jchromb.2015.07.001_bib0125","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1042\/BJ20111685","article-title":"CS055 (Chidamide\/HBI-8000), a novel histone deacetylase inhibitor, induces G1 arrest, ROS-dependent apoptosis and differentiation in human leukaemia cells","volume":"443","author":"Gong","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.jchromb.2015.07.001_bib0130","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00280-012-1847-5","article-title":"study of chidamide (CS055\/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas","volume":"69","author":"Dong","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jchromb.2015.07.001_bib0135","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/bmc.3001","article-title":"Determination of chidamide in rat plasma by LC\u2013MS and its application to pharmacokinetics study","volume":"27","author":"Wang","year":"2013","journal-title":"Biomed. Chromatogr."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023215300696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023215300696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T08:06:00Z","timestamp":1566979560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023215300696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":27,"alternative-id":["S1570023215300696"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2015.07.001","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a sensitive HPLC\u2013MS\/MS method for determination of chidamide (epidaza), a new benzamide class of selective histone deacetylase inhibitor, in human plasma and its clinical application","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2015.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}